Name | tyrphostin a51 |
---|---|
Synonyms |
1,3-Butadiene-1,1,3-tricarbonitrile, 2-amino-4-(3,4,5-trihydroxyphenyl)-, (3Z)-
ag 183 tyrphostin ag 183 1,3-Butadiene-1,1,3-tricarbonitrile, 2-amino-4-(3,4,5-trihydroxyphenyl)-, (Z)- tyrphostin 51 (3Z)-2-Amino-4-(3,4,5-trihydroxyphenyl)buta-1,3-diene-1,1,3-tricarbonitrile (3Z)-2-Amino-4-(3,4,5-trihydroxyphenyl)-1,3-butadiene-1,1,3-tricarbonitrile |
Description | (Z)-Tyrphostin A51 is the Z configuration of Lanoconazole A51. Tyrphostin A51 is a potent protein tyrosine kinase (PTK) inhibitor. Tyrphostin A51 inhibits the volume-dependent release of [3H]taurine in a dose-dependent manner. Tyrphostin A51 markedly reduces cellular tyrosyl phosphorylation level. Tyrphostin A51 inhibits both basal and EGF-induced human bone cell proliferation[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 788.2±60.0 °C at 760 mmHg |
Melting Point | 278ºC |
Molecular Formula | C13H8N4O3 |
Molecular Weight | 268.228 |
Flash Point | 430.5±32.9 °C |
Exact Mass | 268.059631 |
PSA | 158.08000 |
LogP | 0.04 |
Vapour Pressure | 0.0±2.8 mmHg at 25°C |
Index of Refraction | 1.757 |
Storage condition | 2-8°C |
WGK Germany | 3 |
---|